$ALNY
ALNYLAM PHARMACEUTICALS, INC.

2017 Q2 Form 10-Q Financial Statement

#000156459017008948 Filed on May 05, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2017 Q1 2016 Q4
Revenue $15.93M $18.96M $17.50M
YoY Change 83.13% 159.73% 130.26%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $45.80M $38.50M $27.90M
YoY Change 154.44% 82.46% 62.21%
% of Gross Profit
Research & Development $90.60M $86.98M $105.0M
YoY Change 8.93% -9.65% 26.81%
% of Gross Profit
Depreciation & Amortization $3.100M $3.000M $3.000M
YoY Change -22.5% -34.8% -41.18%
% of Gross Profit
Operating Expenses $136.4M $125.5M $132.9M
YoY Change 34.84% 6.9% 32.8%
Operating Profit -$106.5M
YoY Change -3.2%
Interest Expense $2.600M $2.100M $2.200M
YoY Change 23.81% 16.67% 37.5%
% of Operating Profit
Other Income/Expense, Net -$500.0K -$779.0K $300.0K
YoY Change -121.54% -111.04% 50.0%
Pretax Income -$118.4M -$107.3M -$112.9M
YoY Change 31.39% 4.19% 24.48%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$118.4M -$107.3M -$112.9M
YoY Change 31.39% 4.19% 24.48%
Net Earnings / Revenue -743.28% -565.88% -645.34%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.344M -$1.248M -$1.316M
COMMON SHARES
Basic Shares Outstanding 86.19M 86.01M 85.81M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2017 Q1 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $923.3M $556.9M $617.8M
YoY Change 9.52% -43.15% -39.97%
Cash & Equivalents $408.7M $171.1M $193.6M
Short-Term Investments $514.6M $385.8M $424.2M
Other Short-Term Assets $22.00M $18.10M $21.70M
YoY Change -0.9% -34.42% 30.72%
Inventory
Prepaid Expenses
Receivables $15.40M $19.50M $23.30M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $960.7M $597.2M $671.9M
YoY Change 8.18% -43.13% -39.22%
LONG-TERM ASSETS
Property, Plant & Equipment $147.5M $130.0M $114.6M
YoY Change 166.27% 253.02% 311.95%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $174.6M $255.3M $324.8M
YoY Change -39.21% 11.68% 28.99%
Other Assets $151.5M $1.471M $1.562M
YoY Change 10199.12% 0.0% 6.19%
Total Long-Term Assets $473.6M $536.7M $590.9M
YoY Change -4.15% 101.12% 110.21%
TOTAL ASSETS
Total Short-Term Assets $960.7M $597.2M $671.9M
Total Long-Term Assets $473.6M $536.7M $590.9M
Total Assets $1.434B $1.134B $1.263B
YoY Change 3.77% -13.9% -8.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.20M $25.37M $54.47M
YoY Change 80.91% 45.46% 224.45%
Accrued Expenses $43.80M $31.84M $42.12M
YoY Change 16.64% 3.37% 46.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $108.7M $95.79M $131.7M
YoY Change 54.02% 44.32% 112.08%
LONG-TERM LIABILITIES
Long-Term Debt $150.0M $150.0M $150.0M
YoY Change 0.0%
Other Long-Term Liabilities $52.60M $3.184M $3.067M
YoY Change 2860.05% 131.9% 135.74%
Total Long-Term Liabilities $202.6M $3.184M $3.067M
YoY Change 11301.24% 131.9% 135.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $108.7M $95.79M $131.7M
Total Long-Term Liabilities $202.6M $3.184M $3.067M
Total Liabilities $311.3M $303.0M $342.6M
YoY Change 9.74% 136.93% 181.28%
SHAREHOLDERS EQUITY
Retained Earnings -$1.764B -$1.657B
YoY Change 30.71% 32.9%
Common Stock $2.629B $2.610B
YoY Change 3.18% 4.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.123B $830.9M $920.2M
YoY Change
Total Liabilities & Shareholders Equity $1.434B $1.134B $1.263B
YoY Change 3.77% -13.9% -8.92%

Cashflow Statement

Concept 2017 Q2 2017 Q1 2016 Q4
OPERATING ACTIVITIES
Net Income -$118.4M -$107.3M -$112.9M
YoY Change 31.39% 4.19% 24.48%
Depreciation, Depletion And Amortization $3.100M $3.000M $3.000M
YoY Change -22.5% -34.8% -41.18%
Cash From Operating Activities -$81.10M -$100.3M -$78.30M
YoY Change 15.53% 19.98% 47.74%
INVESTING ACTIVITIES
Capital Expenditures -$21.60M $36.15M -$19.90M
YoY Change 71.43% 1210.33% 541.94%
Acquisitions
YoY Change
Other Investing Activities -$46.00M $111.2M $120.2M
YoY Change 44.65% -14.33% 47.85%
Cash From Investing Activities -$67.70M $75.10M $100.4M
YoY Change 52.82% -36.3% 28.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 386.3M 2.700M 3.000M
YoY Change 150.36% -83.23% -53.85%
NET CHANGE
Cash From Operating Activities -81.10M -100.3M -78.30M
Cash From Investing Activities -67.70M 75.10M 100.4M
Cash From Financing Activities 386.3M 2.700M 3.000M
Net Change In Cash 237.5M -22.50M 25.10M
YoY Change 496.73% -144.64% -21.07%
FREE CASH FLOW
Cash From Operating Activities -$81.10M -$100.3M -$78.30M
Capital Expenditures -$21.60M $36.15M -$19.90M
Free Cash Flow -$59.50M -$136.5M -$58.40M
YoY Change 3.3% 58.01% 17.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
ALNYLAM PHARMACEUTICALS, INC.
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001178670
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 us-gaap Available For Sale Securities Equity Securities Current
AvailableForSaleSecuritiesEquitySecuritiesCurrent
2682000
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
19457000
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
193617000
CY2017Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
385843000
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Trading Symbol
TradingSymbol
ALNY
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42118000
CY2016Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
150000000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1562000
CY2016Q4 us-gaap Assets
Assets
1262810000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
54465000
CY2016Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
1576000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
131699000
CY2016Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
8431000
CY2016Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
424185000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
86984000
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
86190192
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
171079000
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18127000
CY2017Q1 us-gaap Assets Current
AssetsCurrent
597188000
CY2017Q1 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
255305000
CY2017Q1 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
150000000
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1471000
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86068086
CY2016Q1 us-gaap License And Services Revenue
LicenseAndServicesRevenue
7345000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
96273000
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
129962000
CY2017Q1 us-gaap Assets
Assets
1133926000
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2627969000
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31842000
CY2017Q1 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
1818000
CY2017Q1 us-gaap Secured Long Term Debt
SecuredLongTermDebt
150000000
CY2017Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
8006000
CY2017Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
46049000
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
861000
CY2017Q1 us-gaap Liabilities
Liabilities
303025000
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86068086
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
25371000
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33828000
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1764101000
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1133926000
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
36755000
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
95786000
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3184000
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
830901000
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2017Q1 us-gaap License And Services Revenue
LicenseAndServicesRevenue
18960000
CY2016Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
150000000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33441000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1656811000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
920221000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3067000
CY2016Q4 us-gaap Liabilities
Liabilities
342589000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
859000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2609614000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85941344
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85941344
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38487000
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21100000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1262810000
CY2016Q4 us-gaap Available For Sale Securities Equity Securities Current
AvailableForSaleSecuritiesEquitySecuritiesCurrent
8997000
CY2016Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
23334000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21744000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
671877000
CY2016Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
324799000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
114572000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
33540000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
49392000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
125471000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
117373000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-106511000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-110028000
CY2017Q1 us-gaap Investment Income Net
InvestmentIncomeNet
2128000
CY2016Q1 us-gaap Investment Income Net
InvestmentIncomeNet
1813000
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2907000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5241000
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-779000
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7054000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-107290000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-102974000
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.25
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.21
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
86027000
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
85277000
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-8224000
CY2016Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
5156000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-107677000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-116354000
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3000000
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4601000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
15717000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
23480000
CY2017Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
551000
CY2016Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
331000
CY2017Q1 us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
-1549000
CY2017Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-3877000
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3708000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11067000
CY2017Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-10855000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-100330000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36152000
CY2017Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
86803000
CY2017Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
198031000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
231278000
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1936000
CY2017Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-1549000
CY2016Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
516000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2010000
CY2016Q1 us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
5156000
CY2017Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
608000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
347000
CY2016Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-4305000
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-128000
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2579000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-83623000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2759000
CY2016Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
164561000
CY2016Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
294317000
CY2016Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
9057000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
75076000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
117940000
CY2017Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2769000
CY2016Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1824000
CY2016Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
14301000
CY2017Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
53000
CY2016Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
59000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2716000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
16066000
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-22538000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
50383000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
180895000
CY2017Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p></div>
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12211000
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10368000
CY2017Q1 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-89300000
CY2017Q1 alny Investments Classified As Cash And Cash Equivalent Original Maturities
InvestmentsClassifiedAsCashAndCashEquivalentOriginalMaturities
P90D
CY2017Q1 alny Investment Maturity Period Minimum
InvestmentMaturityPeriodMinimum
P90D
CY2017Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
642184000
CY2017Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
42000
CY2017Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1078000
CY2017Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
641148000
CY2016Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
750537000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
57000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1610000
CY2016Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
748984000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
386115000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
256069000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
385843000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
255305000
CY2015Q4 us-gaap Gain Contingency Unrecorded Amount
GainContingencyUnrecordedAmount
8000000

Files In Submission

Name View Source Status
0001564590-17-008948-index-headers.html Edgar Link pending
0001564590-17-008948-index.html Edgar Link pending
0001564590-17-008948.txt Edgar Link pending
0001564590-17-008948-xbrl.zip Edgar Link pending
alny-10q_20170331.htm Edgar Link pending
alny-20170331.xml Edgar Link completed
alny-20170331.xsd Edgar Link pending
alny-20170331_cal.xml Edgar Link unprocessable
alny-20170331_def.xml Edgar Link unprocessable
alny-20170331_lab.xml Edgar Link unprocessable
alny-20170331_pre.xml Edgar Link unprocessable
alny-ex311_11.htm Edgar Link pending
alny-ex312_10.htm Edgar Link pending
alny-ex321_9.htm Edgar Link pending
alny-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g201705050027172534256.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending